Hanna Stedt
Clinical Lecturer
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
hanna.stedt@uef.fi
Publications
13/13 items-
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)
Aho, Sonja; Osterlund, Emerik; Ristimäki, Ari; Nieminen, Lasse; Sundström, Jari; Mäkinen, Markus J; Kuopio, Teijo; Kytölä, Soili; Ålgars, Annika; Ristamäki, Raija; Heervä, Eetu; Kallio, Raija; Halonen, Päivi; Soveri, Leena-Maija; Nordin, Arno; Uutela, Aki; Salminen, Tapio; Stedt, Hanna; Lamminmäki, Annamarja; Muhonen, Timo; Kononen, Juha; Glimelius, Bengt; Isoniemi, Helena; Lehto, Juho T; Lehtomäki, Kaisa; Osterlund, Pia. 2024. Cancers. 16: -
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts
Osterlund, Emerik; Ristimäki, Ari; Mäkinen, Markus J.; Kytölä, Soili; Kononen, Juha; Pfeiffer, Per; Soveri, Leena‐Maija; Keinänen, Mauri; Sorbye, Halfdan; Nunes, Luís; Salminen, Tapio; Nieminen, Lasse; Uutela, Aki; Halonen, Päivi; Ålgars, Annika; Sundström, Jari; Kallio, Raija; Ristamäki, Raija; Lamminmäki, Annamarja; Stedt, Hanna; Heervä, Eetu; Kuopio, Teijo; Sjöblom, Tobias; Isoniemi, Helena; Glimelius, Bengt; Osterlund, Pia. 2023. International journal of cancer. 2024; 154: 488-503 -
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
Lehtomäki, Kaisa; Soveri, Leena-Maija; Osterlund, Emerik; Lamminmäki, Annamarja; Uutela, Aki; Heervä, Eetu; Halonen, Päivi; Stedt, Hanna; Aho, Sonja; Muhonen, Timo; Ålgars, Annika; Salminen, Tapio; Kallio, Raija; Nordin, Arno; Aroviita, Laura; Nyandoto, Paul; Kononen, Juha; Glimelius, Bengt; Ristamäki, Raija; Isoniemi, Helena; Osterlund, Pia. 2023. Journal of clinical medicine. 12: -
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study
Uutela, Aki; Osterlund, Emerik; Halonen, Päivi; Kallio, Raija; Ålgars, Annika; Salminen, Tapio; Lamminmäki, Annamarja; Soveri, Leena-Maija; Ristamäki, Raija; Lehtomäki, Kaisa; Stedt, Hanna; Heervä, Eetu; Muhonen, Timo; Kononen, Juha; Nordin, Arno; Ovissi, Ali; Kytölä, Soili; Keinänen, Mauri; Sundström, Jari; Nieminen, Lasse; Mäkinen, Markus J.; Kuopio, Teijo; Ristimäki, Ari; Isoniemi, Helena; Osterlund, Pia. 2022. British journal of cancer. 127: 686-694 -
Up-regulation of Mismatch Repair Pathway by Suicide Gene Therapy: Implications on the use of Temozolomide Treatment in Malignant Glioma
Samaranayake, Haritha Dhammika; Olsson, Venla; Kurkipuro, Jere Tuomas; Määttä, Ann-Marie; Stedt, Hanna; Kärkkäinen, Hanna-Riikka; Kaikkonen, Minna U; Taavitsainen, Miia; Vuorio, Taina; Parker, Nigel; Ylä-Herttuala, Seppo. 2018. Journal of cancer science & therapy. 10: 214-222 -
Gene Therapy of Malignant Glioma: Alternative Strategies and Combination Therapies
Stedt Hanna. 2015. Publications of the University of Eastern Finland. Dissertations in Health Sciences -
Tomato thymidine kinase-based suicide gene therapy for malignant glioma - an alternative for Herpes Simplex virus-1 thymidine kinase
Stedt H, Samaranayake H, Kurkipuro J, Wirth G, Christiansen LS, Vuorio T, Määttä A-M, Pi¨kur J, Ylä-Herttuala S. 2015. Cancer gene therapy. 22: 130-137 -
Soluble Vascular Endothelial Growth Factor Receptor-1 Improves Therapeutic Efficacy of Suicide Gene Therapy in an Angiogenesis-Independent Manner
Samaranayake Haritha D, Pikkarainen Jere T, Wirth Thomas, Stedt Hanna, Lesch Hanna P, Dragneva Galina, Vuorio Taina, Määttä Ann-Mari, Airenne Kari, Ylä-Herttuala Seppo. 2014. Human gene therapy. 25: 942-954 -
Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide
Stedt H, Samaranayake H, Pikkarainen J, Määttä AM, Alasaarela L, Airenne K, Ylä-Herttuala S. 2013. Gene therapy. 20: -- -
Endothelium-specific overexpression of human vascular endothelial growth factor-D in mice leads to increased tumor frequency and a reduced lifespan
Kotimaa AA, Zainana AM, Pulkkinen E, Huusko J, Heinonen SE, Kholová I, Stedt H, Lesch HP, Ylä-Herttuala S. 2012. Journal of gene medicine. 2012 Mar;14(3): 182-90